◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ4 2025Nov 07, 2025Q4 2024Nov 06, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
+Operating Income 80.0M 2.3B -- -- -- --
Operating Margin % 4.4% 62.5% -- -- -- --
+Ordinary Income 1.8B 3.8B -- -- -- --
Revenue Growth % -51.3% -- -- -- -- --
Line ItemQ4 2025Nov 07, 2025Q4 2024Nov 06, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
Current Assets 32.9B 30.8B -- -- -- --
Total Assets 92.4B 76.3B 62.6B 56.9B 37.4B 35.8B
Current Liabilities 29.3B 23.6B -- -- -- --
Total Liabilities 52.3B 42.1B 35.9B 31.9B 18.7B 21.0B
Total Equity 40.1B 34.2B 26.7B 25.0B 18.7B 14.8B
Equity Ratio -- -- 0.42 0.44 0.50 0.41
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...